CARDIOMYOPATHY, HYPERTROPHIC
Clinical trials for CARDIOMYOPATHY, HYPERTROPHIC explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, HYPERTROPHIC trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, HYPERTROPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart rhythm showdown: ablation may beat drugs for ventricular tachycardia
Disease control OngoingThis trial tests whether a procedure called catheter ablation works better than anti-arrhythmic drugs for people with structural heart disease who have had a dangerous fast heart rhythm (ventricular tachycardia). About 162 participants will be randomly assigned to either ablation…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug could help teens with rare heart disease
Disease control OngoingThis study tests a drug called mavacamten in 44 teenagers aged 12 to 18 who have a condition where the heart muscle is too thick and blocks blood flow. The goal is to see if the drug can reduce the blockage and improve symptoms. Participants are randomly assigned to receive eithe…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Heart drug mavacamten under microscope: can it reshape damaged heart muscle?
Disease control OngoingThis phase 4 study tests the drug mavacamten in 63 adults with a type of heart muscle disease called obstructive hypertrophic cardiomyopathy. The goal is to see if the drug can improve heart structure, measured by MRI, and ease symptoms like shortness of breath. Participants take…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC